LPL and B-cell chronic lymphocytic leukemia: This is controversial to the high LPL and PPARα expression in aggressive (and highly proliferative) CLL cells and raises the question of what role LDLs and fatty acids might play during different CLL disease stages, therapy-evading LSCs, and their TME.